GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Psyence Group Inc (OTCPK:PSYGF) » Definitions » Cash-to-Debt

PSYGF (Psyence Group) Cash-to-Debt : No Debt (1) (As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Psyence Group Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Psyence Group's cash to debt ratio for the quarter that ended in Dec. 2024 was No Debt (1).

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Psyence Group could pay off its debt using the cash in hand for the quarter that ended in Dec. 2024.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for Psyence Group's Cash-to-Debt or its related term are showing as below:

PSYGF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06   Med: 4.84   Max: No Debt
Current: 6.01

During the past 5 years, Psyence Group's highest Cash to Debt Ratio was No Debt. The lowest was 0.06. And the median was 4.84.

PSYGF's Cash-to-Debt is ranked better than
70.71% of 1007 companies
in the Drug Manufacturers industry
Industry Median: 1.02 vs PSYGF: 6.01

Psyence Group Cash-to-Debt Historical Data

The historical data trend for Psyence Group's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Psyence Group Cash-to-Debt Chart

Psyence Group Annual Data
Trend Dec19 Dec20 Mar22 Mar23 Mar24
Cash-to-Debt
No Debt No Debt 2.63 51.24 0.09

Psyence Group Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.84 0.09 0.06 1.54 No Debt

Competitive Comparison of Psyence Group's Cash-to-Debt

For the Drug Manufacturers - General subindustry, Psyence Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Group's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Psyence Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Psyence Group's Cash-to-Debt falls into.


;
;

Psyence Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Psyence Group's Cash to Debt Ratio for the fiscal year that ended in Mar. 2024 is calculated as:

Psyence Group's Cash to Debt Ratio for the quarter that ended in Dec. 2024 is calculated as:

Psyence Group had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Psyence Group  (OTCPK:PSYGF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Psyence Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Psyence Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Group Business Description

Traded in Other Exchanges
Address
121 Richmond Street West, Penthouse Suite, 1300, Toronto, ON, CAN, M5H 2K1
Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness.

Psyence Group Headlines

No Headlines